Regeneus (ASX:RGS) secures $4.5 M for osteoarthritis trials
Clinical-stage regenerative medicine company Regeneus (RGS) has secured up to $4.5 million…
Regeneus Ltd (ASX:RGS)
About Regeneus Ltd
Key Information
RGS In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 21/07/2022 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 388.17KB | 1.4K |
| 30/06/2022 | Notification of cessation of securities - RGS | 21.5KB | 271 |
| 17/06/2022 | Change of Director's Interest Notice | 226.14KB | 418 |
| 10/06/2022 | Regeneus CEO cements support | 136.16KB | 3.7K |
| 29/04/2022 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 396.68KB | 2.2K |
| 08/03/2022 | Notification of cessation of securities - RGS | 21.51KB | 313 |
| 04/03/2022 | Final Director's Interest Notice | 179.75KB | 280 |
| 02/03/2022 | Director Appointment/Resignation | 133.38KB | 546 |